Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
49.7M
-
Number of holders
-
509
-
Total 13F shares, excl. options
-
50.8M
-
Shares change
-
-2.13M
-
Total reported value, excl. options
-
$7.72B
-
Value change
-
-$316M
-
Put/Call ratio
-
1
-
Number of buys
-
257
-
Number of sells
-
-322
-
Price
-
$151.73
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q2 2025
661 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q2 2025.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 509 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.8M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (5.81M shares), WELLINGTON MANAGEMENT GROUP LLP (3.77M shares), BlackRock, Inc. (3.66M shares), Allspring Global Investments Holdings, LLC (2.29M shares), STATE STREET CORP (1.86M shares), NOMURA HOLDINGS INC (1.57M shares), ARIEL INVESTMENTS, LLC (1.42M shares), Invesco Ltd. (1.24M shares), GEODE CAPITAL MANAGEMENT, LLC (1.23M shares), and HARRIS ASSOCIATES L P (1.16M shares).
This table shows the top 509 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.